Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 6/1998

Content (13 Articles)

ORIGINAL ARTICLE

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

Catia Marzolini, Laurent A. Decosterd, Fei Shen, Marc Gander, Serge Leyvraz, Jean Bauer, Thierry Buclin, Jérôme Biollaz, Ferdy Lejeune

ORIGINAL ARTICLE

Antihelicase action of CI-958, a new drug for prostate cancer

Lapman Lun, Pei-Ming Sun, Charles M. Trubey, Nicholas R. Bachur

ORIGINAL ARTICLE

Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer

Murray S. Webb, Patricia Logan, Peter M. Kanter, Ginette St.-Onge, Karen Gelmon, Troy Harasym, Lawrence D. Mayer, Marcel B. Bally

ORIGINAL ARTICLE

Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration

Moustapha Hassan, Zuzana Hassan, Christina Nilsson, Mohamed Abdel Rehim, Susanne Kumlien, Birgitta Elfsson, Nils Kållberg

ORIGINAL ARTICLE

Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors

Matthew L. Hanley, Gertrude B. Elion, O. Michael Colvin, Paul L. Modrich, Stephen Keir, David J. Adams, Darell D. Bigner, Henry S. Friedman

ORIGINAL ARTICLE

Jasplakinolide: interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma

Hideya Takeuchi, Gulshan Ara, Edward A. Sausville, Beverly Teicher

ORIGINAL ARTICLE

Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer

Colleen J. Gilbert, William P. Petros, James Vredenburgh, Atif Hussein, Maureen Ross, Peter Rubin, Randy Fehdrau, Colleen Cavanaugh, Donald Berry, Craig McKinstry, William P. Peters

ORIGINAL ARTICLE

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically

Primo N. Lara Jr., David R. Gandara, Gregory T. Wurz, Derick Lau, Margaret Uhrich, Corinne Turrell, James Raschko, Martin J. Edelman, Timothy Synold, James Doroshow, Franco Muggia, Edith A. Perez, Mike DeGregorio

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine